ORCID: https://orcid.org/0000-0003-4910-6263; Leuthold, Mila und Schütz, Anne K.
ORCID: https://orcid.org/0000-0001-6398-5757
(2026):
Expression, purification and functional validation of a cancer-associated isoform of the HBx protein from human hepatitis B virus.
In: Protein Expression and Purification, Bd. 238, 106842
[PDF, 2MB]
Abstract
The human hepatitis B virus (HBV) causes hepatitis B, a liver infection that can be acute or chronic. HBV encodes four proteins, among which the X protein (HBx) plays a critical role in viral replication. During chronic HBV infection, in which the viral DNA is integrated into the host genome, the HBx1-120 isoform, comprising the N-terminal 120 residues, is highly expressed. Here, we describe a protocol for the recombinant overexpression and purification of untagged HBx1-120 from bacterial cells. The procedure is compatible with stable isotope labelling in minimal media. Following cell lysis, HBx1-120 was recovered from inclusion bodies (IBs), solubilized in urea, and purified by ion-exchange (IEX) and size-exclusion chromatography (SEC). The purified protein was extensively characterized, including by mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Functionality was confirmed by a pulldown assay with a known interacting partner, Spindlin1. This protocol provides a robust framework to obtain untagged HBx1-120 for structural and functional in vitro studies.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Chemie und Pharmazie > Department Chemie |
| Themengebiete: | 500 Naturwissenschaften und Mathematik > 540 Chemie |
| URN: | urn:nbn:de:bvb:19-epub-130614-8 |
| ISSN: | 10465928 |
| Sprache: | Englisch |
| Dokumenten ID: | 130614 |
| Datum der Veröffentlichung auf Open Access LMU: | 19. Dez. 2025 07:11 |
| Letzte Änderungen: | 19. Dez. 2025 07:11 |
